Cantor Is Slashing Its MEI Pharma Price Target
March 24, 2015 at 17:12 PM EDT
In a report published Tuesday, Cantor Fitzgerald analyst Daniel Brims maintained a Buy rating on MEI Pharma, Inc (NASDAQ: MEIP), while ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.